Exact Mass: 706.1729

Exact Mass Matches: 706.1729

Found 44 metabolites which its exact mass value is equals to given mass value 706.1729, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside

(2R,3R,4S,5R,6R)-2-{[(1R,5S,13R,21R)-5,13-bis(3,4-dihydroxyphenyl)-17,19-dihydroxy-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2(11),3(8),9,15(20),16,18-hexaen-21-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H34O15 (706.1898)


Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside is a member of the class of compounds known as biflavonoids and polyflavonoids. Biflavonoids and polyflavonoids are organic compounds containing at least two flavan/flavone units. These units are usually linked through CC or C-O-C bonds. Some examples include C2-O-C3, C2-O-C4, C3-C3, and C6-C8. Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside can be found in chocolate and cocoa powder, which makes epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside a potential biomarker for the consumption of these food products.

   

6)-glucoside]

3,5,7,4-Tetrahydroxyflavone 3- [ 2",3",4"-triacetyl-alpha-L-arabinopyranosyl- (1->6) -glucoside ]

C32H34O18 (706.1745)


   

6)-glucoside

Kaempferol 3-[2,3,5-triacetyl-alpha-L-arabinofuranosyl-(1-

C32H34O18 (706.1745)


   

Sanggenon S

Sanggenon S

C40H34O12 (706.205)


   
   

Sinocrassoside A5

Sinocrassoside A5

C33H38O17 (706.2109)


   

subulatin

subulatin

C32H34O18 (706.1745)


An alkyl caffeate ester isolated from Lophocolea heterophylla and Jungermannia subulata and has been shown to exhibit antioxidant activity.

   

Kaempferol 3-[2,3,4-triacetyl-alpha-L-arabinopyranosyl-(1->6)-glucoside]

Kaempferol 3-[2,3,4-triacetyl-alpha-L-arabinopyranosyl-(1->6)-glucoside]

C32H34O18 (706.1745)


   

Kaempferol 3-[2,3,5-triacetyl-alpha-L-arabinofuranosyl-(1->6)-glucoside

Kaempferol 3-[2,3,5-triacetyl-alpha-L-arabinofuranosyl-(1->6)-glucoside

C32H34O18 (706.1745)


   

rel-(1S,2R,3R,5S,7R)-7-[(E)-caffeoyloxymethyl]-2,3-di[(E)-caffeoyloxy]-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

rel-(1S,2R,3R,5S,7R)-7-[(E)-caffeoyloxymethyl]-2,3-di[(E)-caffeoyloxy]-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid

C35H30O16 (706.1534)


   

ent-epiafzelechin-(2alpha?O?7,4alpha?8)-ent-afzelechin 3?-O-beta-D-glucopyranoside

ent-epiafzelechin-(2alpha?O?7,4alpha?8)-ent-afzelechin 3?-O-beta-D-glucopyranoside

C36H34O15 (706.1898)


   

Catalporid hexaaceat

Catalporid hexaaceat

C33H38O17 (706.2109)


   

3-O-p-coumaroyl-6-O-feruloyl-beta-D-fructofuranosyl 6-O-acetyl-alpha-D-glucopyranoside

3-O-p-coumaroyl-6-O-feruloyl-beta-D-fructofuranosyl 6-O-acetyl-alpha-D-glucopyranoside

C33H38O17 (706.2109)


   

[(2S,3S,4R,5R,6R)-5-acetyloxy-3-hydroxy-2-methyl-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]oxan-4-yl] acetate

NCGC00381236-01![(2S,3S,4R,5R,6R)-5-acetyloxy-3-hydroxy-2-methyl-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-6-methoxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methoxy]oxan-4-yl] acetate

C33H38O17 (706.2109)


   

calcium,3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

calcium,3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C32H34CaN4O8S2 (706.1444)


   

disodium 2,2-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-butylbenzenesulphonate

disodium 2,2-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-butylbenzenesulphonate

C34H32N2Na2O8S2 (706.1395)


   

W-84 dibromide

W-84 dibromide

C32H44Br2N4O4 (706.1729)


W-84 (dibromide) is a potent allosteric modulator of M2-cholinoceptors, which retards [3H]N-methylscopolamine dissociation. W-84 dibromide can stabilize cholinergic antagonist-receptor complexes. W-84 (dibromide) is a non-competitive muscarinic acetylcholine receptors antagonist with allosteric effects. W-84 (dibromide) protects over additively against an organophosphate-intoxication when applied in combination with atropine[1][2][3].

   

disodium 3,3-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)bis[imino(3-methylpropane-1,3-diyl)]]bis(benzenesulphonate)

disodium 3,3-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)bis[imino(3-methylpropane-1,3-diyl)]]bis(benzenesulphonate)

C34H32N2Na2O8S2 (706.1395)


   

(-)-Epicatechin-(2a-7)(4a-8)-epicatechin 3-O-galactoside

(-)-Epicatechin-(2a-7)(4a-8)-epicatechin 3-O-galactoside

C36H34O15 (706.1898)


   

7-(4-hydroxy-3,5-dimethoxyphenyl)-11-oxo-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

7-(4-hydroxy-3,5-dimethoxyphenyl)-11-oxo-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaene-3-carboxylic acid

C35H30O16 (706.1534)


   

Viridaphin A1 Glucoside

Viridaphin A1 Glucoside

C36H34O15 (706.1898)


A natural product found in Megoura crassicauda.

   

3,4,5-trihydroxy-6-[[3-hydroxy-2-(3-hydroxyphenyl)-4-[3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-chromen-8-yl]-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-2-carboxylic acid

3,4,5-trihydroxy-6-[[3-hydroxy-2-(3-hydroxyphenyl)-4-[3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-chromen-8-yl]-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-2-carboxylic acid

C36H34O15 (706.1898)


   

Isolinariinn C

Isolinariinn C

C33H38O17 (706.2109)


   

ACG416B

ACG416B

C38H36Br2N4 (706.1307)


ACG416B (compound 18) is a potent inhibitor of ChoK (choline kinase) with an IC50 of 0.4 μM. ACG416B renders higher ChoK inhibitory and antiproliferative activities against the HT-29 human colon cancer cell[1].

   

4,10,14-trihydroxy-5-[(1s,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

4,10,14-trihydroxy-5-[(1s,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

C40H34O12 (706.205)


   

2-[(3-{[4-(acetyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate

2-[(3-{[4-(acetyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate

C33H38O17 (706.2109)


   

3-o-p-coumaroyl-6-o-feruloyl-β-d-fructo-furanosyl 6-o-acetyl-α-d-glucopyranoside

NA

C33H38O17 (706.2109)


{"Ingredient_id": "HBIN009373","Ingredient_name": "3-o-p-coumaroyl-6-o-feruloyl-\u03b2-d-fructo-furanosyl 6-o-acetyl-\u03b1-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C33H38O17","Ingredient_Smile": "CC(=O)OCC1C(C(C(C(O1)OC2(C(C(C(O2)COC(=O)C=CC3=CC(=C(C=C3)O)OC)O)OC(=O)C=CC4=CC=C(C=C4)O)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2s,3s,4s,5r,6s)-6-{4-[(r)-[(3s)-3-[(2-{4-[(3r)-3-amino-3-carboxypropoxy]phenyl}-1,2-dihydroxyethylidene)amino]-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6s)-6-{4-[(r)-[(3s)-3-[(2-{4-[(3r)-3-amino-3-carboxypropoxy]phenyl}-1,2-dihydroxyethylidene)amino]-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H34N4O16 (706.197)


   

(2s,3r,4r,5r,6s)-2-[(3-{[(2s,3r,4s,5r,6r)-4-(acetyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate

(2s,3r,4r,5r,6s)-2-[(3-{[(2s,3r,4s,5r,6r)-4-(acetyloxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl)oxy]-4,5-dihydroxy-6-methyloxan-3-yl 2-methylpropanoate

C33H38O17 (706.2109)


   

6-(4-{[3-({2-[4-(3-amino-3-carboxypropoxy)phenyl]-1,2-dihydroxyethylidene}amino)-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(4-{[3-({2-[4-(3-amino-3-carboxypropoxy)phenyl]-1,2-dihydroxyethylidene}amino)-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H34N4O16 (706.197)


   

[(2r,3r,4s,5s)-5-{[(2r,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxolan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[(2r,3r,4s,5s)-5-{[(2r,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)-4-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxolan-2-yl]methyl (2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H38O17 (706.2109)


   

[(2r,3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2s,3s,4r,5s,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxolan-2-yl]methyl acetate

[(2r,3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2s,3s,4r,5s,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxolan-2-yl]methyl acetate

C32H34O18 (706.1745)


   

(1s,10s)-4,10,14-trihydroxy-5-[(1r,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

(1s,10s)-4,10,14-trihydroxy-5-[(1r,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

C40H34O12 (706.205)


   

(3s,5as,6s,10ar)-3-{[(3s,5as,6s,10ar)-6-(acetyloxy)-3-hydroxy-3-(hydroxymethyl)-2-methyl-1,4-dioxo-5ah,6h,10h-pyrazino[1,2-a]indol-10a-yl]disulfanyl}-10a-hydroxy-3-(hydroxymethyl)-2-methyl-1,4-dioxo-5ah,6h,10h-pyrazino[1,2-a]indol-6-yl acetate

(3s,5as,6s,10ar)-3-{[(3s,5as,6s,10ar)-6-(acetyloxy)-3-hydroxy-3-(hydroxymethyl)-2-methyl-1,4-dioxo-5ah,6h,10h-pyrazino[1,2-a]indol-10a-yl]disulfanyl}-10a-hydroxy-3-(hydroxymethyl)-2-methyl-1,4-dioxo-5ah,6h,10h-pyrazino[1,2-a]indol-6-yl acetate

C30H34N4O12S2 (706.1615)


   

6-(1,2-dihydroxyethyl)-5-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4-{[3-(3-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid

6-(1,2-dihydroxyethyl)-5-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4-{[3-(3-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid

C32H34O18 (706.1745)


   

[3,4-bis(acetyloxy)-5-[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]oxolan-2-yl]methyl acetate

[3,4-bis(acetyloxy)-5-[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]oxolan-2-yl]methyl acetate

C32H34O18 (706.1745)


   

4,5-bis(acetyloxy)-2-[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]oxan-3-yl acetate

4,5-bis(acetyloxy)-2-[(6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methoxy]oxan-3-yl acetate

C32H34O18 (706.1745)


   

(2r,3r,4s,5s)-4,5-bis(acetyloxy)-2-{[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxan-3-yl acetate

(2r,3r,4s,5s)-4,5-bis(acetyloxy)-2-{[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxan-3-yl acetate

C32H34O18 (706.1745)


   

(4r,5r,6r)-6-[(1r)-1,2-dihydroxyethyl]-5-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4-{[(2e)-3-(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid

(4r,5r,6r)-6-[(1r)-1,2-dihydroxyethyl]-5-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4-{[(2e)-3-(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoyl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid

C32H34O18 (706.1745)


   

[(2s,3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxolan-2-yl]methyl acetate

[(2s,3s,4r,5r)-3,4-bis(acetyloxy)-5-{[(2r,3s,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}oxolan-2-yl]methyl acetate

C32H34O18 (706.1745)


   

[5-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-3-hydroxy-5-(hydroxymethyl)-4-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxolan-2-yl]methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

[5-({6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-3-hydroxy-5-(hydroxymethyl)-4-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}oxolan-2-yl]methyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate

C33H38O17 (706.2109)


   

(5r,6r,13s,21r)-5,13-bis(3,4-dihydroxyphenyl)-9,17,19,21-tetrahydroxy-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-6-yl (2e)-3-phenylprop-2-enoate

(5r,6r,13s,21r)-5,13-bis(3,4-dihydroxyphenyl)-9,17,19,21-tetrahydroxy-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2,8,10,15,17,19-hexaen-6-yl (2e)-3-phenylprop-2-enoate

C39H30O13 (706.1686)